Skip to content

QSI

Quantum-Si Inc

NASDAQ · Healthcare · Biotechnology · US

$1.09
−2.68%
Ask drillr

Year over year

Reported trailing growth

Revenue
-53.0%
EBITDA
+14.6%
EBIT
+14.0%
EPS
+31.7%
Free cash flow
+2.8%
Operating cash flow
-0.1%

Forward estimates

Based on analyst estimates

Revenue
+142.4%
EBITDA
+5.1%
EPS
+10.5%

Three-year CAGR

Revenue
+50.0%
EBITDA
+3.6%
EBIT
+10.3%
Net income
-0.3%
EPS
+28.2%
Free cash flow
-5.3%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026